Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Common Stock (NQ:NTRB)

7.150 -0.450 (-5.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,014
Open 7.420
Bid (Size) 6.800 (5)
Ask (Size) 7.230 (4)
Prev. Close 7.600
Today's Range 7.050 - 7.600
52wk Range 3.722 - 11.78
Shares Outstanding 6,356,270
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nutriband Inc. (NASDAQ: NTRB) Reports Double-Digit Revenue Increase, Continued Progress on AVERSA Fentanyl Development
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
+57.1%
+57.1%
1 Month
+24.8%
+24.8%
3 Month
+16.8%
+16.8%
6 Month
+74.4%
+74.4%
1 Year
+17.8%
+17.8%

More News

Read More
Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB): A Relentless Mission Rooted in Purpose, Innovation, and Shareholder Value
Via Investor Brand Network
Topics Initial Public Offering
Exposures Securities Market
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Conference
Via Investor Brand Network
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development
Via Investor Brand Network
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Highlights Transdermal Pain Solution on BioMedWire Podcast
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Charts Path to Commercialization
Via Investor Brand Network
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape
Via Investor Brand Network
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2024 Milestones and 2025 Commercialization Goals
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Nutriband Inc. (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare
Via Investor Brand Network
Nutriband CEO Publishes Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Nutriband Inc (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks — Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Nutriband Inc. (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist in Established Category
Via Investor Brand Network
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures Patent in Macao for AVERSA Abuse-Deterrent Technology
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
From Nutriband Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Nutriband Inc. - Common Stock publicly traded?
Yes, Nutriband Inc. - Common Stock is publicly traded.
What exchange does Nutriband Inc. - Common Stock trade on?
Nutriband Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nutriband Inc. - Common Stock?
The ticker symbol for Nutriband Inc. - Common Stock is NTRB on the Nasdaq Stock Market
What is the current price of Nutriband Inc. - Common Stock?
The current price of Nutriband Inc. - Common Stock is 7.150
When was Nutriband Inc. - Common Stock last traded?
The last trade of Nutriband Inc. - Common Stock was at 06/13/25 04:00 PM ET
What is the market capitalization of Nutriband Inc. - Common Stock?
The market capitalization of Nutriband Inc. - Common Stock is 45.45M
How many shares of Nutriband Inc. - Common Stock are outstanding?
Nutriband Inc. - Common Stock has 45M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.